Background HIV-1-infected patients vary considerably by their response to antiretroviral
treatment, drug concentrations in plasma, toxic events, and rate of immune recovery. This …

Background No effective treatments for coronavirus disease 2019 (COVID-19) exist. We
aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be …

Objective To investigate the virological and immunological impact of a structured treatment
interruption (STI) in a cohort of HIV-1 chronically infected patients with a further long-lasting …

BackgroundInfection with drug-resistant human immunodeficiency virus type 1 (HIV-1) can
impair the response to combination therapy. Widespread transmission of drug-resistant …

In healthy blood donors, serological positivity for human cytomegalovirus (HCMV) is associated
with an increased proportion of NK cells bearing the CD94/NKG2C NK cell receptor (…

Objective To determine whether HIV-1 genotyping and expert advice add additional short-term
virologic benefit in guiding antiretroviral changes in HIV+ drug-experienced patients. …

Mutations within cytotoxic T lymphocyte (CTL) epitopes impair T cell recognition, but escape
mutations arising in flanking regions that alter antigen processing have not been defined in …

Background Current strategies for preventing severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. …

The SPREAD Programme investigated prospectively the time trend from September 2002
through December 2005 of transmitted drug resistance (TDR) among 2793 patients in 20 …

The interferon (IFN)‐γ component of the immune response plays an essential role in combating
infectious and non‐infectious diseases. Induction of IFN‐γ secretion by human T and …